MarketCap
Facebook
X
Telegram
Aspira Women's Health Total Shareholders Equity | AWH
Annual Total Shareholders Equity Aspira Women's Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.93 M | -2.56 M | -2.36 M | 6.98 M | 30.2 M | 9.72 M | 8.74 M | 7.15 M | 3.41 M | 3.76 M | 17.5 M | 19.3 M | 26.8 M | 4.67 M | 10.4 M | 4.62 M | -27.3 M |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.2 M | -27.3 M | 6.7 M |
Quarterly Total Shareholders Equity Aspira Women's Health
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.21 M | -4.34 M | -2.68 M | -60 K | -2.56 M | -2.52 M | -3.71 M | -1.36 M | -2.36 M | -659 K | -528 K | 827 K | 6.98 M | 11.2 M | 14.1 M | 21.7 M | 30.2 M | 38.5 M | 46.8 M | 52.3 M | 9.72 M | 9.72 M | 9.72 M | 9.72 M | 8.74 M | 8.74 M | 8.74 M | 8.74 M | 7.15 M | 7.15 M | 7.15 M | 7.15 M | 3.41 M | 3.41 M | 3.41 M | 3.41 M | 3.76 M | 3.76 M | 3.76 M | 3.76 M | 17.5 M | 17.5 M | 17.5 M | 17.5 M | 19.3 M | 19.3 M | 19.3 M | 19.3 M | 26.8 M | 26.8 M | 26.8 M | 26.8 M | 4.67 M | 4.67 M | 4.67 M | 4.67 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 52.3 M | -6.21 M | 10.7 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
CareDx, Inc
CDNA
|
303 M | $ 78.47 | 2.8 % | $ 4.18 B |  USA |
 |
Biomerica
BMRA
|
2.63 M | $ 1.61 | -1.55 % | $ 4.69 M | USA |
 |
Interpace Biosciences
IDXG
|
22.4 M | $ 7.0 | -13.43 % | $ 31 M | USA |
 |
ICON Public Limited Company
ICLR
|
9.19 B | $ 204.67 | 1.5 % | $ 16.1 B |  Irlanda |
 |
Co-Diagnostics
CODX
|
20.6 M | $ 0.25 | -8.24 % | $ 333 K | USA |
 |
Burning Rock Biotech Limited
BNR
|
535 M | $ 13.2 | -0.38 % | $ 139 M |  China |
 |
DarioHealth Corp.
DRIO
|
67.9 M | $ 2.4 | -11.93 % | $ 9.56 M |  Israel |
 |
Myriad Genetics
MYGN
|
368 M | $ 5.97 | -5.17 % | $ 553 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.26 M | $ 4.73 | -5.49 % | $ 3.72 M | USA |
 |
NeoGenomics
NEO
|
837 M | $ 16.85 | 2.18 % | $ 2.16 B | USA |
 |
OPKO Health
OPK
|
1.27 B | $ 1.72 | -1.71 % | $ 1.29 B | USA |
 |
Pacific Biosciences of California
PACB
|
5.35 M | $ 2.3 | -5.35 % | $ 690 M | USA |
 |
Neogen Corporation
NEOG
|
2.09 B | $ 11.75 | 0.6 % | $ 2.56 B | USA |
 |
Precipio
PRPO
|
14.6 M | $ 18.95 | 2.02 % | $ 30.4 M | USA |
 |
Personalis
PSNL
|
261 M | $ 15.76 | 1.32 % | $ 1.41 B | USA |
 |
Sotera Health Company
SHC
|
606 M | $ 16.01 | 0.88 % | $ 4.55 B | USA |
 |
Centogene N.V.
CNTG
|
-25.3 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
1.83 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
548 M | - | 0.12 % | $ 80.1 M | China |
 |
Check-Cap Ltd.
CHEK
|
3.44 M | - | - | $ 9.42 M | Israel |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
14 M | $ 25.62 | 0.55 % | $ 573 M | USA |
 |
Twist Bioscience Corporation
TWST
|
473 M | $ 120.83 | 0.18 % | $ 7.23 B | USA |
 |
Organovo Holdings
ONVO
|
-1.1 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
31.9 M | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
7.25 B | - | -0.91 % | $ 14.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
450 M | - | - | $ 2.69 B | USA |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 257.93 | 1.18 % | $ 28.6 B | USA |
 |
Danaher Corporation
DHR
|
52.5 B | $ 230.45 | 1.76 % | $ 164 B | USA |
 |
IDEXX Laboratories
IDXX
|
1.61 B | $ 676.3 | 0.83 % | $ 54.4 B | USA |
 |
Illumina
ILMN
|
2.72 B | $ 213.05 | 2.43 % | $ 33 B | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 100.61 | -0.09 % | $ 6.79 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-56 M | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
459 M | $ 653.24 | 2.88 % | $ 18.8 B | USA |
 |
Mettler-Toledo International
MTD
|
-23.6 M | $ 1 722.36 | 2.64 % | $ 35.5 B |  Schweiz |
 |
Natera
NTRA
|
1.71 B | $ 319.38 | -12.2 % | $ 43.7 B | USA |
 |
Charles River Laboratories International
CRL
|
3.16 B | $ 338.13 | 8.07 % | $ 16.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
11 B | $ 30.33 | -0.57 % | $ 28.8 B |  Niderland |
 |
QIAGEN N.V.
QGEN
|
3.78 B | $ 50.36 | -0.98 % | $ 10.9 B | Niderland |
 |
RadNet
RDNT
|
1.09 B | $ 75.83 | -2.79 % | $ 5.7 B | USA |
 |
Senseonics Holdings
SENS
|
61 M | $ 8.58 | 7.38 % | $ 358 M | USA |
 |
T2 Biosystems
TTOO
|
-28 M | - | -39.35 % | $ 313 K | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |